Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic?
Saved in:
| Title: | Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic? |
|---|---|
| Authors: | Fefferman ML; Department of Surgery, Endeavor Health, Evanston, IL, USA.; Department of Surgery, University of Chicago, Chicago, IL, USA., Chan K; American College of Surgeons Cancer Programs, Chicago, IL, USA.; Department of Surgery, Loyola University Medical Center, Maywood, IL, USA., Cotler J; American College of Surgeons Cancer Programs, Chicago, IL, USA., Thompson DM; Department of Surgery, Endeavor Health, Evanston, IL, USA.; Department of Surgery, University of Chicago, Chicago, IL, USA., Bleicher RJ; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Kurtzman SH; Department of Surgery, Waterbury Hospital, Waterbury, CT, USA., Dietz JM; Department of Surgery, Case Western Reserve University, Cleveland, OH, USA., Yao K; Department of Surgery, Endeavor Health, Evanston, IL, USA. kyao@northshore.org.; Department of Surgery, University of Chicago, Chicago, IL, USA. kyao@northshore.org. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 May; Vol. 211 (1), pp. 11-22. Date of Electronic Publication: 2025 Jan 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-025-07617-6 |
